Lexicon Stock Market Sentiment

LXRX
 Stock
  

USD 2.13  0.08  3.90%   

Lexicon investor sentiment overview provides quick insight into current market opportunities from investing in Lexicon Pharmaceutcl. The current market sentiment together Lexicon Pharmaceutcl's historical and current headlines can help investors to time the market. Many technical investors use Lexicon Pharmaceutcl stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Additionally, see Lexicon Pharmaceutcl Hype Analysis, Lexicon Pharmaceutcl Correlation and Lexicon Pharmaceutcl Performance.
  
Lexicon Pharmaceutcl stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lexicon daily returns and investor perception about the current pice of Lexicon Pharmaceutcl as well as its diversification or hedging effects on your existing portfolios.

Lexicon Historical Sentiment

Although Lexicon Pharmaceutcl's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Lexicon, such as negative comments on social media and news outlets, may cause fear in the market and push Lexicon Pharmaceutcl's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Lexicon.
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Lexicon Pharmaceutcl's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Lexicon Pharmaceutcl.

Lexicon Pharmaceutcl Sentiment by Major News Outlets

Lexicon Pharmaceutcl Historical Investor Sentiment

Investor biases related to Lexicon Pharmaceutcl's public news can be used to forecast risks associated with investment in Lexicon. The trend in average sentiment can be used to explain how an investor holding Lexicon can time the market purely based on public headlines and social activities around Lexicon Pharmaceutcl. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Lexicon Pharmaceutcl's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Lexicon Pharmaceutcl's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Lexicon Pharmaceutcl's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Lexicon Pharmaceutcl.
over two weeks ago at news.google.com         
The Global Clinical Diagnostics Market is expected to Surge at a CAGR of 7.02 percent During the For...
news
over two weeks ago at news.google.com         
Fallopian Tube Cancer Pipeline Appears Robust With 50 Key Pharma Companies Actively Working in the T...
news
over two weeks ago at Macroaxis         
Is Lexicon (NASDAQ:LXRX) outlook still optimistic?
Macroaxis News
over three weeks ago at news.google.com         
Lexicon Pharmaceuticals will report earnings on Wednesday. - Best Stocks
news
over a month ago at news.google.com         
Carcinoid Syndrome Diarrhea Treatment Market Size And Forecast Lexicon Pharmaceuticals, Novartis Int...
news
over a month ago at www.catholicglobe.org         
Lysosomal Storage Disease LSD Market Size And Forecast Actelion Pharmaceuticals, Amicus Therapeutics...
news
over a month ago at news.google.com         
Private equity firms among Lexicon Pharmaceuticals, Inc.s largest stockholders and were hit after la...
news
over a month ago at www.digitaljournal.com         
IBS Treatment Market Share, Size, Global Growth Opportunities, Driving Factors by Manufacturers, Reg...
news
over two months ago at www.benzinga.com         
nference Launches AI-Driven Platform and Expands Partnership with Mayo Clinic, Offering Access to On...
benzinga news
over two months ago at www.digitaljournal.com         
Muscular Dystrophy Treatment Market 2022 Rising With Immense Development Trends Across The Globe By ...
news
over two months ago at www.prnewswire.com         
Tamas Oravecz Ph.D. named SVP, CSO of the U.S. of Simcere Pharmaceutical Group - PR Newswire
prnewswire News
over three months ago at www.openpr.com         
Carcinoid Syndrome Diarrhea Treatment Market Experts Signals Revenue, Development, Market Trends, Ke...
news
over three months ago at www.marketbeat.com         
Lexicon Pharmaceuticals Receives New Coverage from Analysts at Piper Sandler - MarketBeat
Marketbeat News
over three months ago at www.streetinsider.com         
Lexicon Pharmaceutcl exotic insider transaction detected
Street Insider News
over three months ago at www.elpasoinc.com         
Lexicon Announces Full Exercise and Closing of Options to Purchase Additional Shares in ... - El Pas...
inc News
Far too much social signal, news, headlines, and media speculation about Lexicon Pharmaceutcl that are available to investors today. That information is available publicly through Lexicon media outlets and privately through word of mouth or via Lexicon internal channels. However, regardless of the origin, that massive amount of Lexicon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lexicon Pharmaceutcl news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lexicon Pharmaceutcl relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lexicon Pharmaceutcl's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lexicon Pharmaceutcl alpha.

Lexicon Pharmaceutcl Performance against DOW

 Price Growth (%)  
       Timeline  
1
Financial Statements09/02/2022
2
Muscular Dystrophy Treatment Market 2022 Rising With Immense...09/19/2022
3
EPS Estimate09/30/2022
4
Private equity firms among Lexicon Pharmaceuticals, Inc.s la...10/11/2022
5
EPS Reported11/09/2022
6
The Global Clinical Diagnostics Market is expected to Surge ...11/15/2022
Additionally, see Lexicon Pharmaceutcl Hype Analysis, Lexicon Pharmaceutcl Correlation and Lexicon Pharmaceutcl Performance. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for analysis

When running Lexicon Pharmaceutcl price analysis, check to measure Lexicon Pharmaceutcl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceutcl is operating at the current time. Most of Lexicon Pharmaceutcl's value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceutcl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexicon Pharmaceutcl's price. Additionally, you may evaluate how the addition of Lexicon Pharmaceutcl to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Lexicon Pharmaceutcl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceutcl. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceutcl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.63) 
Market Capitalization
381.2 M
Quarterly Revenue Growth YOY
0.7
Return On Assets
(0.33) 
Return On Equity
(0.69) 
The market value of Lexicon Pharmaceutcl is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceutcl's value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceutcl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceutcl's market value can be influenced by many factors that don't directly affect Lexicon Pharmaceutcl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceutcl's value and its price as these two are different measures arrived at by different means. Investors typically determine Lexicon Pharmaceutcl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceutcl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.